245 related articles for article (PubMed ID: 1967277)
1. Modulation of lymphokine release and cytolytic activities by activating peripheral blood lymphocytes via CD2.
Valentin H; Groux H; Gelin C; Chretien I; Bernard A
J Immunol; 1990 Feb; 144(3):875-82. PubMed ID: 1967277
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis of activated CD8+/CD57+ T cells is induced by some combinations of anti-CD2 mAb.
Rouleau M; Bernard A; Lantz O; Vernant JP; Charpentier B; Senik A
J Immunol; 1993 Oct; 151(7):3547-56. PubMed ID: 7690806
[TBL] [Abstract][Full Text] [Related]
3. T cell activation via CD2 [T, gp50]: the role of accessory cells in activating resting T cells via CD2.
Huet S; Wakasugi H; Sterkers G; Gilmour J; Tursz T; Boumsell L; Bernard A
J Immunol; 1986 Sep; 137(5):1420-8. PubMed ID: 2427570
[TBL] [Abstract][Full Text] [Related]
4. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
[TBL] [Abstract][Full Text] [Related]
5. The required interaction between monocytes and peripheral blood T lymphocytes (T-PBL) upon activation via CD2 or CD3. Role of HLA class I molecules from accessory cells and the differential response of T-PBL subsets.
Huet S; Boumsell L; Dausset J; Degos L; Bernard A
Eur J Immunol; 1988 Aug; 18(8):1187-94. PubMed ID: 2901355
[TBL] [Abstract][Full Text] [Related]
6. Role of CD2 in regulation of CD3- LGL function.
Mason A; Bernard A; Smyth MJ; Ortaldo JR
Eur Cytokine Netw; 1991; 2(1):31-7. PubMed ID: 1714784
[TBL] [Abstract][Full Text] [Related]
7. Trispecific F(ab')3 derivatives that use cooperative signaling via the TCR/CD3 complex and CD2 to activate and redirect resting cytotoxic T cells.
Tutt A; Stevenson GT; Glennie MJ
J Immunol; 1991 Jul; 147(1):60-9. PubMed ID: 1675655
[TBL] [Abstract][Full Text] [Related]
8. Activation of human cytolytic cells through CD2/T11. Comparison of the requirements for the induction and direction of lysis of tumor targets by T cells and NK cells.
Scott CF; Bolender S; McIntyre GD; Holldack J; Lambert JM; Venkatesh YP; Morimoto C; Ritz J; Schlossman SF
J Immunol; 1989 Jun; 142(11):4105-12. PubMed ID: 2565930
[TBL] [Abstract][Full Text] [Related]
9. T cell activation via CD2 [T, gp50] molecules: accessory cells are required to trigger T cell activation via CD2-D66 plus CD2-9.6/T11(1) epitopes.
Brottier P; Boumsell L; Gelin C; Bernard A
J Immunol; 1985 Sep; 135(3):1624-31. PubMed ID: 2410496
[TBL] [Abstract][Full Text] [Related]
10. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
Bolhuis RL; Roozemond RC; van de Griend RJ
J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
[TBL] [Abstract][Full Text] [Related]
11. Mitogenic CD2 monoclonal antibody pairs predispose peripheral T cells to undergo apoptosis on interaction with a third CD2 monoclonal antibody.
Rouleau M; Mollereau B; Bernard A; Metivier D; Rosenthal-Allieri MA; Charpentier B; Senik A
J Immunol; 1994 May; 152(10):4861-72. PubMed ID: 7909825
[TBL] [Abstract][Full Text] [Related]
12. A murine very late activation antigen-like extracellular matrix receptor involved in CD2- and lymphocyte function-associated antigen-1-independent killer-target cell interaction.
Takahashi K; Nakamura T; Koyanagi M; Kato K; Hashimoto Y; Yagita H; Okumura K
J Immunol; 1990 Dec; 145(12):4371-9. PubMed ID: 1979586
[TBL] [Abstract][Full Text] [Related]
13. IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures.
Spits H; Yssel H; Paliard X; Kastelein R; Figdor C; de Vries JE
J Immunol; 1988 Jul; 141(1):29-36. PubMed ID: 2454260
[TBL] [Abstract][Full Text] [Related]
14. Generation of lymphokine-activated killer activity in T cells. Possible regulatory circuits.
Geller RL; Smyth MJ; Strobl SL; Bach FH; Ruscetti FW; Longo DL; Ochoa AC
J Immunol; 1991 May; 146(10):3280-8. PubMed ID: 1673980
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-4 differentially regulates interleukin-2-mediated and CD2-mediated induction of human lymphokine-activated killer effectors.
Robinet E; Kamoun M; Farace F; Chouaib S
Eur J Immunol; 1992 Nov; 22(11):2861-5. PubMed ID: 1358624
[TBL] [Abstract][Full Text] [Related]
16. Enhanced lymphokine production and lymphokine receptor expression in multiple antibody-stimulated human CD4+ peripheral blood lymphocytes.
Conlon KC; Ochoa AC; Kopp WC; Ortaldo JR; Urba WJ; Longo DL; Young HA
J Immunol; 1992 Nov; 149(10):3278-89. PubMed ID: 1358968
[TBL] [Abstract][Full Text] [Related]
17. Generation of cytolytic activity with anti-CD3 monoclonal antibodies involves both IL-2-independent and -dependent components.
Stohl W; Tovar Z; Talal N
J Immunol; 1990 May; 144(10):3718-25. PubMed ID: 2139672
[TBL] [Abstract][Full Text] [Related]
18. "CD3low" human thymocyte populations can readily be triggered via the CD2 and/or CD28 activation pathways whereas the CD3 pathway remains nonfunctional.
Pierres A; Cerdan C; Lopez M; Mawas C; Olive D
J Immunol; 1990 Feb; 144(4):1202-7. PubMed ID: 1968076
[TBL] [Abstract][Full Text] [Related]
19. Contribution of tyrosine kinases to the selective orientation of human CD4+ bifunctional cloned T cells toward proliferation or cytolytic function.
Eljaafari A; Soula M; Dorval I; Pirenne H; Quelvennec E; Bernard A; Fagard R; Sterkers G
J Immunol; 1994 Nov; 153(9):3882-9. PubMed ID: 7930601
[TBL] [Abstract][Full Text] [Related]
20. Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens.
Weil-Hillman G; Fisch P; Prieve AF; Sosman JA; Hank JA; Sondel PM
Cancer Res; 1989 Jul; 49(13):3680-8. PubMed ID: 2471587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
